الصفحة الرئيسية>>Signaling Pathways>> Others>>Fabomotizole hydrochloride (CM346 hydrochloride)

Fabomotizole hydrochloride (CM346 hydrochloride) (Synonyms: SM-346)

رقم الكتالوجGC30903

هيدروكلوريد فابوموتيزول (CM346 هيدروكلوريد) (CM346 هيدروكلوريد) هو دواء مزيل للقلق.

Products are for research use only. Not for human use. We do not sell to patients.

Fabomotizole hydrochloride (CM346 hydrochloride) التركيب الكيميائي

Cas No.: 173352-39-1

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
180٫00
متوفر
5mg
198٫00
متوفر
10mg
352٫00
متوفر
50mg
1251٫00
متوفر
100mg
1663٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Fabomotizole Hcl (CM346 Hcl) is an anxiolytic drug; produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions.IC50 value:Target: anxiolytic agent Afobazole's mechanism of action remains poorly defined however, with GABAergic, NGF and BDNF release promoting, MT1 receptor antagonism, MT3 receptor antagonism, and sigma agonism suggested as potential mechanisms. Afobazole was shown to inhibit MAO-A reversibly and there might be also some involvement with serotonin receptors. Afobazole has found little clinical use outside of Russia and has not been evaluated by the FDA.

[1]. Afobazole, From Wikipedia

مراجعات

Review for Fabomotizole hydrochloride (CM346 hydrochloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 5 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Fabomotizole hydrochloride (CM346 hydrochloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.